The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Letter/Comment
An announcement of the Final Rule issued by the IRS.
Magazine & Journal Articles
In this page, AHRMM recommends these 3 proactive activities in the event of economic downturn.
Issue Brief
This learning lab covers alarm safety management in the health care supply chain field.
Toolkits/Methodology
How-to guide to managing IV disruptions.
Advisory
New Guidance on Humidity Levels in the Operating Room
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<